ELASOMERAN
UNII EPK39PL4R4

Substance Identification & Data

This profile provides standardized clinical and technical data for Elasomeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EPK39PL4R4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2430046-03-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

EPK39PL4R4

CAS Registry Number

2430046-03-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ELASOMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C172736

National Cancer Institute reference terminology for clinical and research data.

INN ID

12065

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elasomeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELASOMERAN

Common Names & Synonyms

ELASOMERAN [INN]

ELASOMERAN [JAN]

ELASOMERAN [WHO-DD]

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODONOPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K986P AND V987P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; GENBANK ID MN908947.3) SPIKE (S) GLYCOPROTEIN, FURTHER OPTIMIZED BY TWO ADDITIONAL STOP CODONS, FLANKED BY AN ARTIFICIAL 5' UNTRANSLATED REGION (UTR) AND A 3' UTR DERIVED FROM THE HUMAN ALPHA GLOBIN GENE (HBA1) AND TERMINATED BY A 3' POLY(A) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)

MODERNA COVID-19 VACCINE RNA

MRNA-BASED VACCINE ENCODING A PRE-FUSION STABILIZED SPIKE PROTEIN FROM THE 2019-NOVEL CORONAVIRUS (2019-NCOV)

RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN (986-PROLINE,987-PROLINE)-SPECIFYING POLY(A)-TAILED MESSENGER CX-024414), INNER SALT

SPIKEVAX MRNA